Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc is a renowned pharmaceutical company that develops and commercialises products intended to treat central nervous system diseases. The company operates globally. Supernus Pharmaceuticals operates in the healthcare sector, specifically within the pharmaceutical industry. The company’s expertise lies in its unique product portfolio supporting neurological and psychiatric wellness. These engaging products have positioned Supernus as a distinguished entity within the pharmaceutical industry. The company is currently working on treatment for hypermobility in Parkinson’s disease, treatment-resistant depression and severe epilepsy. Diversify your virtual portfolio by following SUPN shares on eToro.